Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Immunome Inc. shareholders rejected Amendment to Our Amended and Restated Certificate of Incorporation to Reflect New Delaware Law Provisions Regarding Officer Exculpation at the 2023-06-07 meeting.
- Proposal
- charter amendment
- Outcome
- failed
- Meeting
- 2023-06-07
Exact text from the filing
Proposal 2: Amendment to Our Amended and Restated Certificate of Incorporation to Reflect New Delaware Law Provisions Regarding Officer Exculpation The amendment of the Company’s Amended and Restated Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation was not approved by an affirmative vote of a majority of the shares of common stock outstanding and entitled to vote at the Annual Meeting, with the following votes tabulated: For Against Abstain Broker Non-Vote Total 3,528,592 86,542 4,771 4,115,553 7,735,458
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Immunome Inc. shareholders approved Election of Class III Directors for a Three-Year Term Expiring in 2026 at the 2023-06-07 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-06-07
Exact text from the filing
Proposal 1: Election of Class III Directors for a Three-Year Term Expiring in 2026 The following three nominees were elected to serve as Class III directors until the 2026 Annual Meeting of Stockholders of the Company and until their respective successors are elected and qualified, with the following votes tabulated: For Withheld Broker Non-Vote Total Richard A. Baron 2,897,767 722,138 4,115,553 7,735,458 Philip Wagenheim 3,287,880 332,025 4,115,553 7,735,458
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Immunome Inc. shareholders approved Ratification of the Selection of Ernst & Young LLP as the Company's Independent Registered Public Accounting Firm for Fiscal Year 2023 at the 2023-06-07 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-06-07
Exact text from the filing
Proposal 3: Ratification of the Selection of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for Fiscal Year 2023 The selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for fiscal year 2023 was ratified, with the following votes tabulated: For Against Abstain Total 7,578,396 153,921 3,141 7,735,458
View on SEC.gov